Aktuellt
SENASTE
Redeye is positive about SenzaGen’s acquisition of ToxHub, an Italian toxicology services company specializing in toxicological risk assessment and regulatory strategy consulting. We argue ToxHub complements SenzaGen’s offering and believe it is essential that ToxHub is profitable. We make some changes in our model and increase our base case from SEK17 to SEK18.
LÄS MER
